To our health: training tomorrow’s health science leaders
Shocking statistics show that Attention Deficit Hyperactivity Disorder (ADHD) affects an estimated one in every 20 children in Canada. Left untreated, these kids can have trouble learning and become hyperactive, as well as develop more troubling problems later on in life, including substance addiction and other mental health issues.
During her time as a McGill PhD student in Rehabilitation Science, Marie Brossard-Racine, PhD’12, conducted important research on children suffering from ADHD. With the support of a Richard and Edith Strauss Fellowship, she was able to make great strides in her project, which aimed to better understand the relationship between attention, motor functions and performance in every activity, such as handwriting, among children with ADHD. Projects such as Racine’s are essential in finding ways to help treat ADHD.
“For me, the Richard and Edith Strauss Fellowship was more than a source of financial support,” she says. “When I first received this award, I felt that the graduate committee had confidence in my potential as a future independent investigator, which gave me more self-confidence in my career choice and greater belief in my abilities.”
A total of eight Richard and Edith Strauss Fellowships were created in the Faculty of Medicine thanks to the generosity of the Richard and Edith Strauss Canada Foundation. The fellowships are helping advance the Faculty’s education, research and health care delivery mission while providing opportunities to talented students.
Also partnering with the Faculty of Medicine to eradicate disease is the Cole Foundation. The Foundation’s latest gift supports scientists at McGill as well as the Université de Montréal and the Université du Québec's Institut national de la recherche scientifique - Institut Armand-Frappier. The commitment includes fellowship grants to support research into pediatric and young adult leukemia and lymphoma.
“This support from the Cole Foundation gives a major boost to the young scientists in Montreal focusing efforts on pediatric and young adult leukemia and lymphoma,” says Dr. David Eidelman, Vice-Principal of Health Affairs and Dean of Medicine. “Leveraging the research being conducted across sister universities and institutes helps us stay at the forefront in our fight against disease, especially in current economic times. The Foundation's support is invaluable to these efforts.”